Skip to main content

Table 3 Patient–reported immunosuppressive medication use

From: Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective

Current medications (n = 83)

n (%)

None

29 (35.0)

Anti-Malarial (Hydroxychloroquine or Chloroquine)

23 (27.7)

Methotrexate

22 (26.5)

Prednisolone

10 (12.0)

Azathioprine

8 (9.6)

Mycophenolate (Mofetil or Sodium)

7 (8.4)

Intravenous Immunoglobulin

6 (7.2)

Adalimumab

4 (4.8)

Infliximab

3 (3.6)

Rituximab

2 (2.4)

Tocilizumab

1(1.2)

Cyclophosphamide

0

Taking two medicationsa

20 (24.1)

Talking three or more medicationsa

8 (9.6)

  1. aPatients on more than one medication are counted in more than one line of the table